COMP <GO>
OSCR vs UNH // ENTERPRISE SCALE & MARKET CAP
Oscar Health Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: OSCR 3
— UNH 11
▲ ENTERPRISE SCALE & MARKET CAP LEADER: UNH
LAST: $30.37 (-1.36%) • MKT CAP: $9.50B
market-cap
$9.50B
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
market-cap
$364.66B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OSCR VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OSCR | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 88.57% | -47.57 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 11.47% | -46.47 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 11.51% | 6.48% | +5.03 | OSCR | /fcf-yield <GO> |
| Operating Margin | -60.00% | 4.82% | -64.82 | UNH | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 3.14% | -63.14 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 39.00% | 6.46% | +32.54 | OSCR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 3.12 | -2.67 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.74% | +0.06 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.5 | 56.0 | -14.57 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | 0.33 | +0.64 | OSCR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.0x | 17.1x | +5.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $9.50B | $364.66B | -$355.16B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OSCR REV | UNH REV | OSCR GROSS % | UNH GROSS % | OSCR FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $28.6M | $447.57B | 44.0% | 88.7% | $1.09B | $16.07B |
| FY 2024 | $20.6M | $400.28B | 44.0% | 88.3% | $977.3M | $20.70B |
| FY 2023 | $21.4M | $371.62B | 44.0% | 89.6% | -$273.1M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OSCR // BETA 0.97
UNH // BETA 0.33